Literature DB >> 2866301

Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques.

S P Fisher-Hoch, M E Price, R B Craven, F M Price, D N Forthall, D R Sasso, S M Scott, J B McCormick.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 2866301     DOI： 10.1016/s0140-6736(85)90752-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  The enigmatic haemorrhagic fevers.

Authors:  V Suresh
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

2.  Lassa fever.

Authors:  J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

3.  Crimean-Congo hemorrhagic fever: Risk factors and control measures for the infection abatement.

Authors:  Saadia Aslam; Muhammad Shahzad Latif; Muhammad Daud; Zia Ur Rahman; Bushra Tabassum; Muhammad Sohail Riaz; Anwar Khan; Muhammad Tariq; Tayyab Husnain
Journal:  Biomed Rep       Date:  2015-11-18

4.  Exchange transfusion of a patient with fulminant Lassa fever.

Authors:  D Cummins; D Bennett; S J Machin
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

5.  Historical Lassa fever reports and 30-year clinical update.

Authors:  Abe M Macher; Martin S Wolfe
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

6.  Air evacuation under high-level biosafety containment: the aeromedical isolation team.

Authors:  G W Christopher; E M Eitzen
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

Review 7.  Mapping the zoonotic niche of Lassa fever in Africa.

Authors:  Adrian Q N Mylne; David M Pigott; Joshua Longbottom; Freya Shearer; Kirsten A Duda; Jane P Messina; Daniel J Weiss; Catherine L Moyes; Nick Golding; Simon I Hay
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-06-17       Impact factor: 2.184

8.  Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever.

Authors:  Giovanni Lo Iacono; Andrew A Cunningham; Elisabeth Fichet-Calvet; Robert F Garry; Donald S Grant; Sheik Humarr Khan; Melissa Leach; Lina M Moses; John S Schieffelin; Jeffrey G Shaffer; Colleen T Webb; James L N Wood
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

9.  Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.

Authors:  Matthew L Boisen; Jessica N Hartnett; Jeffrey G Shaffer; Augustine Goba; Mambu Momoh; John Demby Sandi; Mohamed Fullah; Diana K S Nelson; Duane J Bush; Megan M Rowland; Megan L Heinrich; Anatoliy P Koval; Robert W Cross; Kayla G Barnes; Anna E Lachenauer; Aaron E Lin; Mahan Nekoui; Dylan Kotliar; Sarah M Winnicki; Katherine J Siddle; Michael Gbakie; Mbalu Fonnie; Veronica J Koroma; Lansana Kanneh; Peter C Kulakosky; Kathryn M Hastie; Russell B Wilson; Kristian G Andersen; Onikepe O Folarin; Christian T Happi; Pardis C Sabeti; Thomas W Geisbert; Erica Ollmann Saphire; S Humarr Khan; Donald S Grant; John S Schieffelin; Luis M Branco; Robert F Garry
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

Review 10.  Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review.

Authors:  Mona Hersi; Adrienne Stevens; Pauline Quach; Candyce Hamel; Kednapa Thavorn; Chantelle Garritty; Becky Skidmore; Constanza Vallenas; Susan L Norris; Matthias Egger; Sergey Eremin; Mauricio Ferri; Nahoko Shindo; David Moher
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.